Healthcare - Medical - Devices - NASDAQ - US
$ 3.42
-0.581 %
$ 361 M
Market Cap
-10.36
P/E
CASH FLOW STATEMENT
-21.7 M
OPERATING CASH FLOW
55 M
INVESTING CASH FLOW
2.14 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
MaxCyte, Inc.
| Net Income | -37.9 M |
| Depreciation & Amortization | 4.17 M |
| Capital Expenditures | -3.7 M |
| Stock-Based Compensation | 14 M |
| Change in Working Capital | 3.82 M |
| Others | -13 M |
| Free Cash Flow | -25.4 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (37.9) | (23.6) | (19.1) | (11.8) | (12.9) | (8.9) | (9.9) | (3.3) | (1.4) | (1.8) | (1.0) | (2.0) |
| Depreciation & Amortization | 4.2 | 2.7 | 1.4 | 1.0 | 0.6 | 0.3 | 0.1 | 0.1 | 93.3 K | 92 K | 0.1 | 0.1 |
| Deferred Income Tax | 0 | 0 | 0.6 | 0.3 | 37.3 K | 96.4 K | 0 | 0 | 20 K | 0 | 0 | 0 |
| Stock Based Compensation | 14.0 | 11.8 | 8.0 | 2.5 | 1.8 | 1.3 | 0.5 | 0.2 | 1.2 K | 95.6 K | 5.7 K | 36.7 K |
| Other Operating Activities | (5.7) | (2.5) | 57 K | 0.1 | 76.9 K | 74.7 K | 0.1 | 81.5 K | 0.1 | 77.9 K | 60.4 K | 32.6 K |
| Change in Working Capital | 3.8 | (3.2) | (1.6) | (0.9) | 1.6 | (3.5) | (0.5) | 0.7 | 1.1 | (0.4) | 0.2 | (0.3) |
| Cash From Operations | (21.7) | (14.8) | (10.7) | (8.8) | (8.8) | (10.5) | (9.7) | (2.3) | (0.2) | (1.9) | (0.6) | (2.1) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | (3.7) | (18.5) | (3.8) | (2.1) | (1.3) | (0.7) | (0.6) | (0.2) | 94.5 K | (0.1) | 49.5 K | 17.4 K |
| Other Items | 58.7 | (6.3) | (191.2) | (14.5) | 1.7 | (3.1) | 0 | 0 | 0 | 0 | 0 | 5.9 K |
| Cash From Investing Activities | 55.0 | (24.8) | (195.0) | (16.6) | 0.5 | (3.8) | (0.6) | (0.2) | 94.5 K | (0.1) | 49.5 K | 11.5 K |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | (5.0) | 63.7 K | (0.2) | 3.2 K | 14.3 K | 16.6 K | 54.4 K | 3.0 | 46.3 K | 1.4 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.9 | 2 885.6 | 3.6 | 0.4 | 0.1 | 0.2 | 16.2 K | 50.7 K | (0.7) | 1.6 | 0 | 0 |
| Cash From Financing Activities | 2.1 | 2.9 | 234.7 | 28.9 | 12.3 | 0.2 | 23.9 | 11.9 | (0.7) | 4.7 | 46.3 K | 1.4 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | 35.4 | (36.7) | 29.0 | 3.5 | 4.0 | (14.1) | 13.6 | 9.3 | (1.0) | 2.6 | (0.7) | (0.8) |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (25.4) | (33.3) | (14.5) | (10.9) | (10.1) | (11.2) | (10.3) | (2.6) | (0.3) | (2.1) | (0.6) | (2.1) |